Has Elise Olsen, MD received payments from drug or device companies?

Yes. Drug and device makers reported $63,547 in general payments to Elise Olsen, MD across 53 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Elise Olsen, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Elise Olsen, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Elise Olsen, MD

Dermatology · Durham, NCNPI 1598708042

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $57,142 of the $63,547 with a category attached, or 89.9%. It is spread thinly across 11 manufacturers, the largest accounting for just 21.4%. Reporting peaked in 2023 at $21,224 and has fallen 96.7% since, to $700 in 2025. Among dermatology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$63,547in general payments, 2019–2025

Across 53 payments — averaging $1199.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Eli Lilly$14K
Kyowa Kirin, Inc.$12K
Helsinn Therapeutics (U.S.), Inc.$10K
Pfizer$9K
Otsuka Pharmaceutical Development & Commercialization, Inc.$6K
Sumitomo Pharma America, Inc.$5K
plus $9K from 5 others

$57,133in research payments, 2019–2025

Across 7 payments — averaging $8161.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Kyowa Kirin, Inc.$26K
Aclaris Therapeutics, Inc.$11K
Pfizer$11K
Incyte Corporation$9K

What the payments were for

Consulting fees$57,14290%
Speaking & faculty fees$3,5006%
Travel & lodging$2,1523%
Food & beverage$7391%
Education$140%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Eli Lilly	7	$13,579
Kyowa Kirin, Inc.	9	$11,549
Helsinn Therapeutics (U.S.), Inc.	8	$9,682
Pfizer	16	$8,753
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$5,513
Sumitomo Pharma America, Inc.	2	$5,264
Aclaris Therapeutics, Inc.	6	$5,023
Myovant Sciences Inc.	1	$2,870
Sun Pharmaceutical Industries Inc.	1	$700
Almirall LLC	1	$600
Bausch Health US, LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

POTELIGEO$11,380
VALCHLOR$9,515
OLUMIANT$4,800
MYFEMBREE$2,599
LITFULO$830
Leqselvi$700

How this compares

$63,547 in reported general payments places this provider in the 95th percentile of 475 dermatology providers in North Carolina.

See all dermatology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$36,510

Medicare patients

126

Services billed

407

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
PegasysPeginterferon Alfa-2a	114	$511,614
ZolinzaVorinostat	13	$90,557
Bexarotene	84	$68,079
Acitretin	27	$10,884
Tacrolimus	18	$2,633
MethotrexateMethotrexate Sodium	71	$1,861
Hydrocortisone	65	$1,569
Betamethasone Dipropionate	44	$1,255
Dutasteride	41	$1,247
Triamcinolone Acetonide	63	$920
Gabapentin	29	$871
Doxycycline Monohydrate	17	$768
Minoxidil	83	$693
Levothyroxine Sodium	40	$648
Mirtazapine	21	$558

Paid to pharmacies, not to this prescriber.

Other dermatology in Durham

Jeffrey ScalesDurham$279K
Negar FooladDurham$76K
Russell HallDurham$65K
Brooke JacksonDurham$38K
Steven FeldmanWinston Salem$3.4M
Nicole SeminaraHuntersville$1.4M
Andrew LeeElkin$702K
Christopher SayedChapel Hill$690K
William HooverConcord$594K
Patrick McElgunnCharlotte$565K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →